BZB-13174-21607
3 vaccinations
4 coded responses
40 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 773 / TX
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-05-19
Survey response — day 42, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: No change since last check in but I realized I had a shorter menstrual cycle after the vaccine. I didnt initially relate it to the vaccine(over 40 years old) , but thought about it after the fact. I have since had a normal period - wanted to repMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-07
- 2021-10-06
-
2021-12-18
Dose 3 — Moderna
- 2021-12-18
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-25
-
2022-01-01
Survey response — day 14, dose 3MedDRA: Fatigue, Headache, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headache, fatigue, low grade fever starting 1-2 days agoMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-08
- 2022-01-15
- 2022-01-22
-
2022-01-29
Survey response — day 42, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory symptom, Rhinorrhoea, SARS-CoV-2 test — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Upper respiratory symptoms- cough, sore throat, nasal discharge · Healthcare visit (other): Drive through COVID testMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — day 42, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-01
- 2022-03-19
- 2022-06-18
-
2022-12-18
Survey response — 12 months, dose 3MedDRA: Influenza, Mobility decreased, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: A self limiting cold- COVID negative Positive for Flu A mid AugustMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-12-18 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 8 — day 42, dose 2
Symptoms: No change since last check in but I realized I had a shorter menstrual cycle after the vaccine. I didnt initially relate it to the vaccine(over 40 years old) , but thought about it after the fact. I have since had a normal period - wanted to rep
Release 10 — day 14, dose 3
Symptoms: Headache, fatigue, low grade fever starting 1-2 days ago
Release 11 — day 42, dose 3
Symptoms: Upper respiratory symptoms- cough, sore throat, nasal discharge
Healthcare visit (other): Drive through COVID test
Release 12 — 12 months, dose 3
Symptoms: A self limiting cold- COVID negative Positive for Flu A mid August
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release